König, Hannah http://orcid.org/0000-0002-4515-8405
König, Hans-Helmut
Gallinat, Jürgen
Lambert, Martin
Karow, Anne
Peth, Judith
Schulz, Holger
Konnopka, Alexander
Clinical trials referenced in this document:
Documents that mention this clinical trial
Excess costs of mental disorders by level of severity
https://doi.org/10.1007/s00127-022-02298-8
Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER) (Pre-results)
https://doi.org/10.1136/bmjopen-2019-036021
Funding for this research was provided by:
innovation fund of the federal joint committee (01NVF16018)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 13 July 2021
Accepted: 5 May 2022
First Online: 31 May 2022
Declarations
:
: JG has received research funding from the German Federal Ministry of Education and Research, German Science Foundation, and speaker fees from Lundbeck, Janssen-Cilag, Lilly, Otsuka and Boehringer. ML has received consultant or speaker fees from AstraZeneca, Bristol-Myers Squibb, Lilly Deutschland GmbH, Janssen Cilag GmbH, Lundbeck GmbH, Otsuka Pharma GmbH, Roche Deutschland Holding GmbH, Sanovi Aventis, Trommsdorff GmbH & Co KG. AKW has received consultant or speaker fees from Lilly Deutschland GmbH, Janssen Cilag GmbH, Lundbeck GmbH, Otsuka Pharma GmbH, Roche Deutschland Holding GmbH.
: The RECOVER study has obtained ethics approval from the ethics committee of the Hamburg Medical Association (PV5672) have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The written consent of all participants was obtained prior to the study.
: Informed consent was obtained from all individual participants included in the study.
: This study includes only anonymized data. The study participants provided informed consent that anonymized study data will be used for publications.